Abiopharma

🔍 SUEN JACOB (Executive)

Company: AIRGAIN INC (AIRG)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 37,314 shares of Common Stock at $4.1192 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | shares_owned_after: 284,431.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 1,000 shares of Common Stock at $5.0 per share (Direct)
  Date: 2026-03-23 | Code: S | equity_swap_involved: false | shares_owned_after: 283,431.00 | transaction_form_type: 4 | Footnotes: F4, F3

Footnotes:

• F1: The sale reported in this column represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs). The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The Reporting Person has executed an instruction letter for the automatic sale of such sell to cover shares intended to satisfy the affirmative defense conditions of Rule 10b5-1.
• F2: Represents a weighted average sales price calculated by the broker executing the sell to cover transactions. These shares were sold as part of a block trade in multiple transactions, and the Reporting Person undertakes to provide to the issuer, any security holder of the Issuer or the SEC staff, upon request, full information regarding the number of shares sold at each separate sales price.
• F3: Includes RSUs.
• F4: The sales reported in this column were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 12, 2025.